Skip to main content
. 2019 Sep 30;130(8):1877–1884. doi: 10.1002/lary.28301

Figure 2.

Figure 2

(A) rTNSS scores following the cryoablation procedure for all subjects (dark line), the nonallergic subcohort (dotted line), and the allergic subcohort (light line). (B) The proportion of subjects with improvements exceeding the rTNSS MCID for all subjects (dark line), the nonallergic subcohort (dotted line), and the allergic subcohort (light line). Error bars represent standard deviation. Statistically significant improvements from baseline (P < 0.001) are identified by: *All subjects; †nonallergic subcohort; ‡allergic subcohort. MCID = minimum clinically important difference; rTNSS = Reflective Total Nasal Symptom Score.